Norwegian Cruise Line, Aura Biosciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures were lower this morning, with the Dow futures falling around 200 points on Monday.

Shares of Norwegian Cruise Line Holdings Ltd (NYSE:NCLH) fell in pre-market trading following first-quarter results.

Norwegian Cruise Line reported quarterly earnings of 23 cents per share which beat the analyst consensus estimate of 14 cents per share. The company reported quarterly sales of $2.331 billion which missed the analyst consensus estimate of $2.357 billion.

The company also cut its FY2026 adjusted EPS guidance from $2.38 to $1.45-$1.79.

Norwegian Cruise Line shares dipped 4.9% to $17.89 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

Xanadu Quantum Technologies (NASDAQ:XNDU) shares dipped 66.9% to $11.97 in pre-market trading. Xanadu will report first quarter financial results on May 14.
Tuniu Corp (NASDAQ:TOUR) fell 14.2% to $6.10 in pre-market trading.
Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG) shares tumbled 7.4% to $31.50 in pre-market trading after surging 89% on Friday. Hemab Therapeutics priced its upsized initial public offering of 16.75 million common shares at $18.00 per share.
Nextdoor Holdings Inc (NYSE:NXDR) fell 7.3% to $1.53 in pre-market trading.
Evolus Inc (NASDAQ:EOLS) fell 6.2% to $5.00 in pre-market trading. Evolus will report first quarter financial results on May 4.
Valneva SE (NASDAQ:VALN) declined 6.2% to $5.02 in pre-market trading.
Aura Biosciences Inc (NASDAQ:AURA) fell 5.8% to $6.60 in pre-market trading after the company announced a proposed public offering of common stock and pre-funded warrants. The company also named Natalie Holles as new CEO.
Enovis Corp (NYSE:ENOV) declined 5.7% to $22.27 in pre-market trading.
Spyre Therapeutics Inc (NASDAQ:SYRE) dipped 5.4% to $65.70 in pre-market trading. Spyre Therapeutics announced grants of inducement awards.